Revenue (Tables)

3 Months Ended

Dec. 28, 2024

Revenue from Contract with Customer [Abstract]

Disaggregation of Revenue

The following tables provide revenue from contracts with customers by business and geographic region on a disaggregated basis:    

		Three Months Ended December 28, 2024
Business (in millions)		United States		International		Total
Diagnostics:
	Cytology & Perinatal	$	76.0	$	49.4	$	125.4
	Molecular Diagnostics	262.6		78.5		341.1
	Blood Screening	4.1		—		4.1
Total		$	342.7	$	127.9	$	470.6
Breast Health:
	Breast Imaging	$	215.7	$	65.9	$	281.6
	Interventional Breast Solutions	66.3		21.2		87.5
Total		$	282.0	$	87.1	$	369.1
GYN Surgical		$	121.9	$	44.4	$	166.3
Skeletal Health		$	11.3	$	4.5	$	15.8
		$	757.9	$	263.9	$	1,021.8

		Three Months Ended December 30, 2023
Business (in millions)		United States		International		Total
Diagnostics:
	Cytology & Perinatal	$	69.8	$	50.2	$	120.0
	Molecular Diagnostics	247.6		72.2		319.8
	Blood Screening	8.0		—		8.0
Total		$	325.4	$	122.4	$	447.8
Breast Health:
	Breast Imaging	$	228.4	$	73.0	$	301.4
	Interventional Breast Solutions	61.1		15.2		76.3
Total		$	289.5	$	88.2	$	377.7
GYN Surgical		$	125.1	$	37.1	$	162.2
Skeletal Health		$	13.7	$	11.7	$	25.4
		$	753.7	$	259.4	$	1,013.1

	Three Months Ended
Geographic Regions (in millions)	December 28, 2024		December 30, 2023
United States	$	757.9	$	753.7
Europe	148.9		142.8
Asia-Pacific	59.8		63.8
Rest of World	55.2		52.8
	$	1,021.8	$	1,013.1

The following table provides revenue recognized by source:

	Three Months Ended
Revenue by type (in millions)	December 28, 2024		December 30, 2023
Disposables	$	663.7	$	628.9
Capital equipment, components and software	154.2		199.2
Service	198.6		178.8
Other	5.3		6.2
	$	1,021.8	$	1,013.1